FR940105-0-00051 FR940105-0-00008 8. Section 20.81␣ Data and information previously disclosed to the public is amended in paragraph (a)(3) by removing the phrase ``part 312 of this chapter or other''. §20.85 [Amended] 9. Section 20.85␣ Disclosure to other Federal government departments and agencies is amended in the last sentence by removing the words ``an agreement'' and adding in their place the words ``a written agreement''. 10. Section 20.87 is amended by revising paragraph (a) to read as follows: §20.87 Disclosure to Congress. (a) All records of the Food and Drug Administration shall be disclosed to Congress upon an authorized request. * * * * * 11. Section 20.100 is amended by revising paragraphs (c)(7), (c)(14), (c)(16), and (c)(17) and by adding new paragraphs (c)(35) through (c)(40) to read as follows: §20.100 Applicability; cross-reference to other regulations. * * * * * (c) *␣*␣* * * * * * (7) Food additive petitions, in §§171.1(h) and 571.1(h) of this chapter. * * * * * (14) Investigational new drug notice, in §312.130 of this chapter. * * * * * (16) Master file for a new drug application, in §312.420 of this chapter. (17) New drug application file, in §314.430 of this chapter. * * * * * (35) Premarket approval application, in §814.9 of this chapter. (36) Report of certain adverse experiences with a medical device, in §803.9 of this chapter. (37) Disqualification determination of an institutional review board, in §56.122 of this chapter. (38) Disqualification determination of a nonclinical laboratory, in §58.213 of this chapter. (39) Minutes or records regarding a public advisory committee, in §14.65(c) of this chapter. (40) Data submitted regarding persons receiving an implanted pacemaker device or lead, in §805.25 of this chapter. Dated: December 23, 1993. Michael R. Taylor, Deputy Commissioner for Policy. [FR Doc. 94&hyph;98 Filed 1&hyph;4&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;P
